VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma

被引:110
作者
Chen, HZ
Ye, DF
Xie, X
Chen, BY
Lu, WG
机构
[1] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Sch Med, Womens Hosp, Cent Lab, Hangzhou 310006, Peoples R China
关键词
ovarian neoplasms; endothelium; vascular endothelial growth factor; vascular endothelial growth factor receptors; signal transduction;
D O I
10.1016/j.ygyno.2004.05.056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To investigate the expressions of vascular endothelial growth factor (VEGF), VEGFRs and activation of signal transducers and activators of transcription (STATs) in ovarian epithelial carcinoma and the relationships among them. Methods. The tissue samples of 42 primary ovarian epithelial carcinoma, 29 benign ovarian tumor and 11 normal ovarian tissue were used to determine the expression of VEGF, VEGFR1, VEGFR2, P-STAT1, P-STAT3, P-STAT5 and P-STAT6 proteins by inummohistochemical staining. Results. VEGF in ovarian carcinomas was significantly higher than that in benign and normal ovarian tissues. VEGFRs expression was in agreement with VEGF expression. In tumor cells and endothelial cells of ovarian carcinomas, expressions of P-STAT3 and P-STAT5 were significantly higher than those in benign and normal ovarian tissues. In endothelial cells, the expression of VEGFR1 and P-STAT5 closely correlated with each other, as well as VEGFR2 and P-STAT3. However, in ovarian carcinoma cells, expressions of VEGF, VEGFR1 and VEGFR2 were significantly correlated with P-STAT3 and P-STAT5, but not with P-STAT1 and P-STAT6. Conclusions. There exist overexpressions of VEGF, VEGFRs, and STAT3, STAT5 activation. Furthermore, these results indicate that VEGF secreted by ovarian carcinoma cells may activate STAT pathway via VEGFRs in ovarian carcinoma themselves. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 44 条
  • [1] AbuJawdeh GM, 1996, LAB INVEST, V74, P1105
  • [2] Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells
    Bartoli, M
    Gu, XL
    Tsai, NT
    Venema, RC
    Brooks, SE
    Marrero, MB
    Caldwell, RB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) : 33189 - 33192
  • [3] Berclaz G, 2001, INT J ONCOL, V19, P1155
  • [4] EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA
    BOOCOCK, CA
    CHARNOCKJONES, DS
    SHARKEY, AM
    MCLAREN, J
    BARKER, PJ
    WRIGHT, KA
    TWENTYMAN, PR
    SMITH, SK
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07): : 506 - 516
  • [5] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [6] Cao XM, 1996, MOL CELL BIOL, V16, P1595
  • [7] Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010
  • [8] The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
    Clauss, M
    Weich, H
    Breier, G
    Knies, U
    Rockl, W
    Waltenberger, J
    Risau, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 17629 - 17634
  • [9] Molecular biology of the VEGF and the VEGF receptor family
    Clauss, M
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (05) : 561 - 569
  • [10] FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition
    Cross, MJ
    Claesson-Welsh, L
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (04) : 201 - 207